Follow this preprint
SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, after the third wave, April-November 2021
View ORCID ProfileJackie Kleynhans, View ORCID ProfileStefano Tempia, View ORCID ProfileNicole Wolter, View ORCID ProfileAnne von Gottberg, View ORCID ProfileJinal N. Bhiman, Amelia Buys, View ORCID ProfileJocelyn Moyes, View ORCID ProfileMeredith L. McMorrow, View ORCID ProfileKathleen Kahn, View ORCID ProfileF. Xavier Gómez-Olivé, View ORCID ProfileStephen Tollman, View ORCID ProfileNeil A. Martinson, View ORCID ProfileFloidy Wafawanaka, View ORCID ProfileLimakatso Lebina, View ORCID ProfileJacques du Toit, View ORCID ProfileWaasila Jassat, View ORCID ProfileMzimasi Neti, View ORCID ProfileMarieke Brauer, View ORCID ProfileCheryl Cohen, the PHIRST-C Group
doi: https://doi.org/10.1101/2022.02.10.22270772
Now published in Emerging Infectious Diseases doi: 10.3201/eid2805.220278
Jackie Kleynhans
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
(MPH)Stefano Tempia
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
cCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America
(PhD)Nicole Wolter
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
(PhD)Anne von Gottberg
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
(PhD)Jinal N. Bhiman
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
(PhD)Amelia Buys
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
(MTech)Jocelyn Moyes
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
(MD)Meredith L. McMorrow
bUniversity of the Witwatersrand, Johannesburg, South Africa
dInfluenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa
(MD)Kathleen Kahn
eMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa
(PhD)F. Xavier Gómez-Olivé
eMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa
(PhD)Stephen Tollman
eMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa
(PhD)Neil A. Martinson
fPerinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa
gJohns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America
(MD)Floidy Wafawanaka
eMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa
(MSc)Limakatso Lebina
fPerinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa
hAfrica Health Research Institute, Durban, South Africa
(MD)Jacques du Toit
eMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand, Johannesburg, South Africa
(MD)Waasila Jassat
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
(MD)Mzimasi Neti
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
(MPH)Marieke Brauer
iAmpath Pathology, Pretoria, South Africa
(MMed Path)Cheryl Cohen
aNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
bUniversity of the Witwatersrand, Johannesburg, South Africa
(PhD)
- Appendix[supplements/270772_file02.pdf]
Posted February 15, 2022.
SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, after the third wave, April-November 2021
Jackie Kleynhans, Stefano Tempia, Nicole Wolter, Anne von Gottberg, Jinal N. Bhiman, Amelia Buys, Jocelyn Moyes, Meredith L. McMorrow, Kathleen Kahn, F. Xavier Gómez-Olivé, Stephen Tollman, Neil A. Martinson, Floidy Wafawanaka, Limakatso Lebina, Jacques du Toit, Waasila Jassat, Mzimasi Neti, Marieke Brauer, Cheryl Cohen, the PHIRST-C Group
medRxiv 2022.02.10.22270772; doi: https://doi.org/10.1101/2022.02.10.22270772
Now published in Emerging Infectious Diseases doi: 10.3201/eid2805.220278
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (731)
- Anesthesia (215)
- Cardiovascular Medicine (3131)
- Dermatology (266)
- Emergency Medicine (464)
- Epidemiology (13082)
- Forensic Medicine (14)
- Gastroenterology (869)
- Genetic and Genomic Medicine (4902)
- Geriatric Medicine (451)
- Health Economics (757)
- Health Informatics (3091)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (975)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (503)
- Neurology (4671)
- Nursing (248)
- Nutrition (691)
- Oncology (2406)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (520)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7233)
- Radiology and Imaging (1615)
- Respiratory Medicine (945)
- Rheumatology (463)
- Sports Medicine (403)
- Surgery (520)
- Toxicology (65)
- Transplantation (223)
- Urology (193)